AI assistant
Sending…
DocGo Inc. — Director's Dealing 2022
Mar 22, 2022
33981_dirs_2022-03-21_339d6950-dfdf-484c-8791-70e3e9d92d79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: DocGo Inc. (DCGO)
CIK: 0001822359
Period of Report: 2022-03-11
Reporting Person: Sugrue Stephen (Chief Compliance Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Buy | $3.25 | 2031-01-07 | Common stock (16129) | Direct | |
| Option to Buy | $8.80 | 2031-12-07 | Common stock (250) | Direct | |
| Option to Buy | $3.25 | 2031-01-07 | Common stock (16129) | Direct | |
| Option to Buy | $8.80 | 2031-12-07 | Common stock (250) | Direct | |
| Option to Buy | $3.25 | 2031-01-07 | Common stock (16129) | Direct | |
| Option to Buy | $8.80 | 2031-12-07 | Common stock (250) | Direct | |
| Option to Buy | $3.25 | 2031-01-07 | Common stock (16129) | Direct | |
| Option to Buy | $8.80 | 2031-12-07 | Common stock (250) | Direct |
Footnotes
F1: Mr. Sugrue was granted 64,515 (as converted) options on January 7, 2021, vesting 25% annually over a four-year period.
F2: Mr. Sugrue was granted 1,000 options on December 7, 2021, vesting 25% annually over a four-year period.
More from DocGo Inc.
Proxy Solicitation & Information Statement
2026
Apr 22
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Jan 30
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 16